{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:50:35Z","timestamp":1793397035477,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.rmed.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:09:36Z","timestamp":1565302176000},"page":"33-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"special_numbering":"C","title":["VEGF and FGF-2: Promising targets for the treatment of respiratory disorders"],"prefix":"10.1016","volume":"156","author":[{"given":"Ankit P.","family":"Laddha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh A.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.08.003_bib1","first-page":"1110","article-title":"A review on angiogenesis and its assays, Iran","volume":"15","author":"Tahergorabi","year":"2012","journal-title":"J. Basic Med. Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib2","first-page":"19","article-title":"Angiogenesis in chronic obstructive pulmonary disease","volume":"26","author":"G\u00f3ralczyk","year":"2012","journal-title":"Med. Biol. Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib3","author":"WHO"},{"key":"10.1016\/j.rmed.2019.08.003_bib4","first-page":"49","article-title":"Angiogenesis in chronic obstructive pulmonary disease: a translational appraisal","volume":"3","author":"Matarese","year":"2012","journal-title":"Transl. Med. @ UniSa."},{"key":"10.1016\/j.rmed.2019.08.003_bib5","first-page":"L209","article-title":"Vascular endothelial growth factor in the lung, AJP Lung Cell","volume":"290","author":"Voelkel","year":"2005","journal-title":"Mol. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1378\/chest.11-1536","article-title":"Defect of adaptation to hypoxia in patients with COPD due to reduction of histone deacetylase 7","volume":"141","author":"To","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.08.003_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ACI.0b013e3282f42696","article-title":"Vascular remodelling in asthma","volume":"8","author":"Walters","year":"2008","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/thx.18.3.225","article-title":"Precapillary systemic-pulmonary anastomoses","volume":"18","author":"Turner-Warwick","year":"1963","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.08.003_bib9","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4049\/jimmunol.159.3.1437","article-title":"The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis","volume":"159","author":"Keane","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00109-007-0280-4","article-title":"Hypoxia and chronic lung disease","volume":"85","author":"Tuder","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib11","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib12","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.041359198","article-title":"Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability","volume":"98","author":"Fukumura","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.rmed.2019.08.003_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10623320802092377","article-title":"Napoleone ferrara and the saga of vascular endothelial growth factor","volume":"15","author":"Ribatti","year":"2008","journal-title":"Endothelium"},{"key":"10.1016\/j.rmed.2019.08.003_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.rmed.2019.08.003_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ijc.25134","article-title":"MMP-2 alters VEGF expression via \u03b1V\u03b23 integrin-mediated PI3K\/AKT signaling in A549 lung cancer cells","volume":"127","author":"Chetty","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.rmed.2019.08.003_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MCP.0b013e32832c975a","article-title":"Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer","volume":"15","author":"Lee","year":"2009","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/carcin\/bgp326","article-title":"Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis","volume":"31","author":"Lee","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.rmed.2019.08.003_bib19","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/biom5031266","article-title":"NF-kappaB signaling in chronic inflammatory airway disease","volume":"5","author":"Schuliga","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.rmed.2019.08.003_bib20","doi-asserted-by":"crossref","first-page":"34955","DOI":"10.1074\/jbc.M604616200","article-title":"A novel mechanism of tissue inhibitor of metalloproteinases-1 activation by interleukin-1 in primary human astrocytes","volume":"281","author":"Wilczynska","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/BJ20041739","article-title":"Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter","volume":"388","author":"Xiao","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.rmed.2019.08.003_bib22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.rmed.2019.08.003_bib23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm1105","article-title":"Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung","volume":"10","author":"Lee","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1242\/dev.126.6.1149","article-title":"VEGF is required for growth and survival in neonatal mice","volume":"126","author":"Gerber","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.rmed.2019.08.003_bib25","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/mend-5-12-1806","article-title":"The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA","volume":"5","author":"Houck","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.rmed.2019.08.003_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0167-4781(98)00240-1","article-title":"Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183","volume":"1443","author":"Lei","year":"1998","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"key":"10.1016\/j.rmed.2019.08.003_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1091\/mbc.9.4.875","article-title":"Synthesis, storage, and release of vascular endothelial growth factor vascular permeability factor (VEGF\/VPF) by human mast cells: implications for the biological significance of VEGF(206)","volume":"9","author":"Grutzkau","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.rmed.2019.08.003_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","article-title":"Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells","volume":"161","author":"Ferrara","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.rmed.2019.08.003_bib29","doi-asserted-by":"crossref","first-page":"24203","DOI":"10.1074\/jbc.272.39.24203","article-title":"Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor","volume":"272","author":"Jonca","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib30","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","article-title":"Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms","volume":"267","author":"Houck","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/iub.234","article-title":"Structure and function of VEGF receptors","volume":"61","author":"Stuttfeld","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.rmed.2019.08.003_bib32","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1016\/S0021-9258(18)99049-6","article-title":"The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing","volume":"266","author":"Tischer","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.tpj.6500371","article-title":"Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins","volume":"6","author":"Anfosso","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.rmed.2019.08.003_bib34","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1074\/jbc.271.10.5638","article-title":"Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors: generation of receptor-selective VEGF variants by site-directed mutagenesis","volume":"271","author":"Keyt","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib35","first-page":"519","article-title":"Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family","volume":"5","author":"Shibuya","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.rmed.2019.08.003_bib36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0006-291X(92)90483-2","article-title":"Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor","volume":"187","author":"Terman","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.rmed.2019.08.003_bib37","doi-asserted-by":"crossref","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","article-title":"The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis","volume":"271","author":"Clauss","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2019.08.003_bib39","first-page":"2165","article-title":"Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells, Investig","volume":"37","author":"Takagi","year":"1996","journal-title":"Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib40","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1182\/blood.V91.8.2698.2698_2698_2703","article-title":"Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII","volume":"91","author":"Ronique Ollivier","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2019.08.003_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/thx.2005.040204","article-title":"Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?","volume":"61","author":"Medford","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.08.003_bib42","doi-asserted-by":"crossref","first-page":"L768","DOI":"10.1152\/ajplung.00353.2009","article-title":"VEGF in the lung: a role for novel isoforms","volume":"298","author":"Varet","year":"2010","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-10-27","article-title":"Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury","volume":"10","author":"Medford","year":"2009","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib44","doi-asserted-by":"crossref","first-page":"41202","DOI":"10.1038\/srep41202","article-title":"The role of vascular endothelial growth factor in small-airway remodelling in a rat model of chronic obstructive pulmonary disease","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2019.08.003_bib45","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1535-7163.MCT-06-0044","article-title":"Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts","volume":"5","author":"Nguyen","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.rmed.2019.08.003_bib46","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","article-title":"Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis","volume":"17","author":"Lieu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib47","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/bi9521755","article-title":"X-ray crystal structure of human acidic fibroblast growth factor","volume":"35","author":"Blaber","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.rmed.2019.08.003_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00018-008-8440-4","article-title":"High molecular weight FGF2: the biology of a nuclear growth factor","volume":"66","author":"Chlebova","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/bjc.1992.256","article-title":"Expression of basic fibroblast growth factor, FGFR1 and fgfr2 in normal and malignant human breast, and comparison with other normal tissues","volume":"66","author":"Luqmani","year":"1992","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.rmed.2019.08.003_bib50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2015.07.028","article-title":"Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment","volume":"380","author":"Marech","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.rmed.2019.08.003_bib51","doi-asserted-by":"crossref","first-page":"L429","DOI":"10.1152\/ajplung.2000.279.3.L429","article-title":"Protein kinase C isozymes and the regulation of diverse cell responses","volume":"279","author":"Dempsey","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib52","doi-asserted-by":"crossref","first-page":"C345","DOI":"10.1152\/ajpcell.00216.2007","article-title":"Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation","volume":"294","author":"Black","year":"2008","journal-title":"AJP Cell Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib53","article-title":"Pulmonary arterial hypertension - NORD (national organization for rare disorders)","author":"Hemnes","year":"2015","journal-title":"Natl. Organ. Rare Dis."},{"key":"10.1016\/j.rmed.2019.08.003_bib54","author":"Gandharba Ray"},{"key":"10.1016\/j.rmed.2019.08.003_bib55","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI33452","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"118","author":"Rabinovitch","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.rmed.2019.08.003_bib56","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.rmed.2019.08.003_bib57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/thx.54.5.427","article-title":"Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension","volume":"54","author":"Shehata","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.08.003_bib58","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1164\/rccm.200508-1291OC","article-title":"Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants","volume":"174","author":"Jan\u00e9r","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib59","doi-asserted-by":"crossref","first-page":"L926","DOI":"10.1152\/ajplung.00247.2002","article-title":"Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension","volume":"284","author":"Louzier","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib60","article-title":"Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation","author":"Ambade","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib61","first-page":"207","article-title":"Angiogenin, bFGF and VEGF: angiogenic markers in breath condensate of patients with pulmonary hypertension","volume":"69","author":"Seyfarth","year":"2015","journal-title":"Pneumologie"},{"key":"10.1016\/j.rmed.2019.08.003_bib62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ebiom.2018.06.003","article-title":"IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1\u03b1 and VEGF expression in vascular endothelial cells","volume":"33","author":"Liu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.rmed.2019.08.003_bib63","first-page":"S55","article-title":"Notch3\/VEGF-A axis is involved in proliferation of pulmonary artery smooth muscle: implications in HIV-associated PAH","volume":"12","author":"M.L","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.rmed.2019.08.003_bib64","series-title":"Chronic Obstructive Pulmonary Disease (COPD)","first-page":"41","author":"Copd","year":"2008"},{"key":"10.1016\/j.rmed.2019.08.003_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clim.2010.06.010","article-title":"Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease","volume":"137","author":"Galgani","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/bmj.1.5166.127-b","article-title":"Emphysema","volume":"1","author":"Sangster","year":"1960","journal-title":"Br. Med. J."},{"key":"10.1016\/j.rmed.2019.08.003_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/2159-8290.CD-RW2016-008","article-title":"Hypoxia promotes cancer stem cells via ID2-dependent VHL inactivation","volume":"6","author":"Pahal","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.rmed.2019.08.003_bib68","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/ajrccm.163.6.2009116","article-title":"Cellular and structural bases of chronic obstructive pulmonary disease","volume":"163","author":"Saetta","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib69","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.rmed.2019.08.003_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/thx.2004.023986","article-title":"Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease","volume":"60","author":"Kranenburg","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.08.003_bib71","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib72","first-page":"453","article-title":"Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease","volume":"2","author":"Siafakas","year":"2007","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2019.08.003_bib73","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.kjms.2017.05.014","article-title":"The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: a case\u2013control study","volume":"33","author":"Yu","year":"2017","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib74","first-page":"903","volume":"vol. 5","author":"Jonson-Reid","year":"2013"},{"key":"10.1016\/j.rmed.2019.08.003_bib75","series-title":"WHO - Asthma","author":"Who","year":"2013"},{"key":"10.1016\/j.rmed.2019.08.003_bib76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.13.1.27","article-title":"The pathology of asthma, with special reference to changes in the bronchial mucosa","volume":"13","author":"Dunnill","year":"1960","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.rmed.2019.08.003_bib77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/ajrccm.156.1.9607066","article-title":"Increased vascularity of the bronchial mucosa in mild asthma","volume":"156","author":"Li","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib78","first-page":"1171","article-title":"Mechanics of airway narrowing","volume":"133","author":"Moreno","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2019.08.003_bib79","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI200522037","article-title":"Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation","volume":"115","author":"Baluk","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.rmed.2019.08.003_bib80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1165\/ajrcmb.20.1.3251","article-title":"Vascular endothelial growth factor gene expression in human fetal lung in vitro","volume":"20","author":"Acarregui","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.rmed.2019.08.003_bib81","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1067\/mai.2003.1455","article-title":"TH2 Cytokine-enhanced and TGF-\u03b2-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-\u03b3 and corticosteroids","volume":"111","author":"Wen","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mai.2002.127797","article-title":"Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects","volume":"110","author":"Asai","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187221307779815066","article-title":"VEGF, angiopoietin-1 and -2 in bronchial asthma: new molecular targets in airway angiogenesis and microvascular remodeling","volume":"1","author":"Kanazawa","year":"2008","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.rmed.2019.08.003_bib84","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaci.2005.11.005","article-title":"Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses","volume":"117","author":"Psarras","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib85","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1183\/09031936.00165308","article-title":"Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling","volume":"34","author":"De Luisi","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.08.003_bib86","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1164\/rccm.200507-1105OC","article-title":"Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma","volume":"173","author":"Feltis","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib87","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0463.2002.100501.x","article-title":"Mast cells and angiogenesis: review article","volume":"110","author":"Norrby","year":"2002","journal-title":"APMIS"},{"key":"10.1016\/j.rmed.2019.08.003_bib88","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.08.003_bib89","first-page":"2037","article-title":"Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders","volume":"149","author":"Inoue","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.rmed.2019.08.003_bib90","first-page":"1189","article-title":"Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury","volume":"143","author":"Henke","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.rmed.2019.08.003_bib91","doi-asserted-by":"crossref","first-page":"43000","DOI":"10.1074\/jbc.M510441200","article-title":"Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-\u03b21-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK","volume":"280","author":"Khalil","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib92","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.08.003_bib93","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib94","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1152\/japplphysiol.00202.2004","article-title":"Vascular endothelial growth factor and related molecules in acute lung injury","volume":"97","author":"Mura","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib95","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.2003.009860","article-title":"Angiogenic cytokines in patients with idiopathic interstitial pneumonia","volume":"59","author":"Simler","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.08.003_bib96","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200308-1151OC","article-title":"Pigment epithelium\u2013derived factor in idiopathic pulmonary fibrosis","volume":"170","author":"Cosgrove","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib97","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI36136","article-title":"VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats","volume":"119","author":"Farkas","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.rmed.2019.08.003_bib98","series-title":"What is non-small cell lung cancer?","author":"Society","year":"2014"},{"key":"10.1016\/j.rmed.2019.08.003_bib99","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14728222.2017.1371137","article-title":"VEGF as a potential target in lung cancer","volume":"21","author":"Frezzetti","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.rmed.2019.08.003_bib100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1995-7645(12)60201-6","article-title":"Effect of endostar combined with cisplatin on expression of VEGF and Sema3A of Lewis lung cancer rats","volume":"6","author":"Feng","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib101","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.96.6.3081","article-title":"Epidermal growth factor system regulates mucin production in airways","volume":"96","author":"Takeyama","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib102","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0959-8049(02)00020-5","article-title":"Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration","volume":"38","author":"Dittrich","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.rmed.2019.08.003_bib103","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/emm.2007.41","article-title":"Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation","volume":"39","author":"Hur","year":"2007","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib104","first-page":"86","article-title":"Assessment report for IRESSA","author":"Agency","year":"2009","journal-title":"React. Wkly. NA"},{"key":"10.1016\/j.rmed.2019.08.003_bib105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000442794","article-title":"Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases","volume":"97","author":"Ha","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.rmed.2019.08.003_bib106","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/abbs\/gmv052","article-title":"Effect of diosmetin on airway remodeling in a murine model of chronic asthma","volume":"47","author":"Ge","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.rmed.2019.08.003_bib107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2016.07.072","article-title":"Bevacizumab reduced auto-phosphorylation of VEGFR2 to protect HDM-induced asthma mice","volume":"478","author":"Huang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.rmed.2019.08.003_bib108","article-title":"E.H. Association for research in vision and ophthalmology., in vivo toxicity testing of intravitreal bevacizumab (avastin) and ranibizumab (lucentis) in rat models with and without retinal ganglion cell damage","volume":"49","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.rmed.2019.08.003_bib109","first-page":"2824","article-title":"Effect of early inhalation of budesonide on cyclinD1, VEGF and \u03b1-SMA in asthmatic rats","volume":"10","author":"Yang","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.rmed.2019.08.003_bib110","first-page":"43","article-title":"Teratogenicity study of the new glucocorticosteroid budesonide in rabbits","volume":"37","author":"Kihlstr\u00f6m","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.rmed.2019.08.003_bib111","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaci.2004.07.039","article-title":"Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression","volume":"114","author":"Lee","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2019.08.003_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-016-0490-9","article-title":"Effect of active vitamin d3 on vegf-induced adam 33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment","volume":"18","author":"Kim","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00005-015-0345-y","article-title":"Airway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9","volume":"64","author":"Grzela","year":"2016","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.rmed.2019.08.003_bib115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0093-7754(01)90035-1","article-title":"Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials","volume":"28","author":"Pierre","year":"2001","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.rmed.2019.08.003_bib116","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1753465808092339","article-title":"Review: therapeutic perspectives in bronchial vascular remodeling in COPD","volume":"2","author":"Zanini","year":"2008","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2019.08.003_bib117","unstructured":"X. Zhao, F.Q. Yu, X.J. Huang, B.Y. Xu, Y.L. Li, X.Y. Zhao, H.F. Guo, B. Luan, Azithromycin influences airway remodeling in asthma via the PI3K\/Akt\/MTOR\/HIF-1\u03b1\/VEGF pathway., J. Biol. Regul. Homeost. Agents 32 (n.d.) 1079\u20131088. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30334401 (accessed July 26, 2019)."},{"key":"10.1016\/j.rmed.2019.08.003_bib118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0165-1218(93)90125-W","article-title":"Preclinical toxicology studies with azithromycin: genetic toxicology evaluation","volume":"300","author":"Amacher","year":"1993","journal-title":"Mutat. Res. Toxicol."},{"key":"10.1016\/j.rmed.2019.08.003_bib119","series-title":"1.5 Diffus. Parenchymal Lung Dis.","first-page":"PA3044","article-title":"Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): about 20 cases","author":"Valenzuela","year":"2015"},{"key":"10.1016\/j.rmed.2019.08.003_bib120","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/jcph.752","article-title":"Pharmacokinetic properties of nintedanib in healthy volunteers and patients with advanced cancer","volume":"56","author":"Dallinger","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2019.08.003_bib121","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/aps.2017.202","article-title":"Neotuberostemonine inhibits the differentiation of lung fibroblasts into myofibroblasts in mice by regulating HIF-1\u03b1 signaling","volume":"39","author":"miao Lv","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.rmed.2019.08.003_bib122","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1378\/chest.103.1.101","article-title":"Colchicine in the treatment of pulmonary fibrosis","volume":"103","author":"Peters","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.08.003_bib124","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-14-56","article-title":"Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats","volume":"14","author":"Wan","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yrtph.2018.03.017","article-title":"A pre-clinical safety study of PEGylated recombinant human endostatin (M 2 ES) in Sprague Dawley rats","volume":"95","author":"Geng","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.rmed.2019.08.003_bib126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00313025.2010.493864","article-title":"Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice","volume":"42","author":"Wang","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.rmed.2019.08.003_bib127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0970-2113.83972","article-title":"An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition","volume":"28","author":"Swarnakar","year":"2011","journal-title":"Lung India"},{"key":"10.1016\/j.rmed.2019.08.003_bib130","series-title":"European Public Assessment Report - Inlyta (Axitinib)","first-page":"44","author":"European Medicines Agency","year":"2012"},{"key":"10.1016\/j.rmed.2019.08.003_bib131","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/JTO.0b013e318220c93e","article-title":"Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer","volume":"6","author":"Tan","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.rmed.2019.08.003_bib132","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/11584520-000000000-00000","article-title":"Linifanib","volume":"10","author":"Data","year":"2010","journal-title":"Drugs R"},{"key":"10.1016\/j.rmed.2019.08.003_bib133","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(17)31074-7","article-title":"J-ALEX: alectinib versus crizotinib in ALK -positive lung cancer","volume":"390","author":"Gainor","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2019.08.003_bib134","series-title":"R. Use, Safety Data Sheet","first-page":"1","author":"Identifier","year":"2015"},{"key":"10.1016\/j.rmed.2019.08.003_bib136","first-page":"22","article-title":"Center for drug evaluation and pharmacology review: secukinumab","volume":"9","author":"FDA","year":"1988","journal-title":"Rev. Lit. Arts Am."},{"key":"10.1016\/j.rmed.2019.08.003_bib138","series-title":"Z. International, P. No, Zemfirza INN; Cediranib","first-page":"44","year":"2016"},{"key":"10.1016\/j.rmed.2019.08.003_bib139","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/annonc\/mdr255","article-title":"Phase II trial of ptk787\/zk 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage iiib\/iv non-small-cell lung cancer (nsclc)","volume":"23","author":"Gauler","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.rmed.2019.08.003_bib140","series-title":"Population Pharmacokinetics and Exposure Toxicity Analysis of Vatalanib in Patients with Myelodysplastic Syndromes","author":"Wang","year":"2013"},{"key":"10.1016\/j.rmed.2019.08.003_bib142","volume":"vols. 1\u201349","author":"Society","year":"2006"},{"key":"10.1016\/j.rmed.2019.08.003_bib145","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cllc.2014.09.011","article-title":"Ceritinib (LDK378): a potent alternative to crizotinib for ALK-rearranged non-small-cell lung cancer","volume":"16","author":"Li","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.rmed.2019.08.003_bib146","series-title":"EPAR Ceritinib","first-page":"44","author":"Sussex","year":"2015"},{"key":"10.1016\/j.rmed.2019.08.003_bib147","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bjp.2015.11.008","article-title":"Anti-angiogenic effects of ethanolic extract of Artemisia sieberi compared to its active substance, artemisinin","volume":"26","author":"Abdolmaleki","year":"2016","journal-title":"Braz. J. Pharmacogn."},{"key":"10.1016\/j.rmed.2019.08.003_bib148","first-page":"2945","article-title":"Antiangiogenic properties of Viscum album extracts are associated with endothelial cytotoxicity","volume":"29","author":"Elluru","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib149","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF03401744","article-title":"Curcumin is an in vivo inhibitor of angiogenesis","volume":"4","author":"Arbiser","year":"1998","journal-title":"Mol. Med."},{"key":"10.1016\/j.rmed.2019.08.003_bib150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jff.2014.01.008","article-title":"Camellia sinensis fruit peel extract inhibits angiogenesis and ameliorates obesity induced by high-fat diet in rats","volume":"7","author":"Chaudhary","year":"2014","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.rmed.2019.08.003_bib151","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1021\/jf0257042","article-title":"Antioxidant activities of grape (Vitis vinifera) pomace extracts","volume":"50","author":"Chidambara Murthy","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib152","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/bbrc.2000.3474","article-title":"Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells","volume":"276","author":"Jiang","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.rmed.2019.08.003_bib153","doi-asserted-by":"crossref","first-page":"35501","DOI":"10.1074\/jbc.M302967200","article-title":"Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo","volume":"278","author":"Bai","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rmed.2019.08.003_bib154","article-title":"Inhibitory effects of Ginkgo biloba extract on vascular endothelial growth factor in rat aortic endothelial cells 1","author":"Zhang","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.rmed.2019.08.003_bib155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ptr.2677","article-title":"Ginger's ( Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro","volume":"23","author":"Brown","year":"2009","journal-title":"Phyther. Res."},{"key":"10.1016\/j.rmed.2019.08.003_bib156","first-page":"37","article-title":"[The effect of 20(R)-ginsenoside Rg3 on the differential expression of cell signaling genes and other related genes in human lung adenocarcinoma cell line A549]","volume":"28","author":"Chen","year":"2005","journal-title":"Zhonghua Jiehe He Huxi Zazhi"},{"key":"10.1016\/j.rmed.2019.08.003_bib157","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1073\/pnas.90.7.2690","article-title":"Genistein, a dietary-derived inhibitor of in vitro angiogenesis","volume":"90","author":"Fotsis","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.rmed.2019.08.003_bib158","doi-asserted-by":"crossref","first-page":"L451","DOI":"10.1152\/ajplung.1997.273.2.L451","article-title":"Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis","volume":"273","author":"Barrios","year":"2017","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.rmed.2019.08.003_bib159","first-page":"2635","article-title":"VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel","volume":"29","author":"Shingyoji","year":"2009","journal-title":"Anticancer Res."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119302616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119302616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:55:35Z","timestamp":1760615735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119302616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":150,"alternative-id":["S0954611119302616"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.08.003","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VEGF and FGF-2: Promising targets for the treatment of respiratory disorders","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}